Crossmark

Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational study

Crossref DOI link: https://doi.org/10.1186/s12967-020-02659-4

Published Online: 2020-12-11

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grgurevic, Lovorka http://orcid.org/0000-0002-9814-3178
Novak, Ruder

Trkulja, Vladimir

Hrkac, Stela

Salai, Grgur

Bilandzic, Josko

Hamzic, Lejla Ferhatovic

Milas, Ivan

Vucemilo, Tiha

Balja, Melita Peric

Bilic, Karmen
Funding

Funding for this research was provided by:

Medicinski Fakultet, Sveučilište u Zagrebu (KK01.1.1.01.0008)
License Information

Text and Data Mining valid from 2020-12-01

Version of Record valid from 2020-12-11
More Information

Article History

Received: 21 September 2020

Accepted: 3 December 2020

First Online: 11 December 2020

Ethics approval and consent to participate

: This prospective observational study was approved by the Ethics Committee of the University Hospital Center Sestre milosrdnice (EP-1402/18-3). All participants provided a signed informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below